围生期成分输血的临床应用分析  

Analysis on clinical application of blood component transfusion in obstetric perinatal period

作　　者：何飞燕 徐莉 徐恒仕[3] 

机构地区：[1]上海交通大学医学院附属第九人民医院妇产科,上海201999 [2]上海交通大学医学院附属第九人民医院医务处,上海201999 [3]上海交通大学医学院附属第九人民医院输血科,上海201999

出　　处：《中国医药导报》2017年第30期105-107,共3页China Medical Herald

基　　金：上海市第四轮公共卫生重点学科建设项目(15G WZK0501)

摘　　要：目的通过分析成分血在产科围产期的运用情况,指导临床及时和合理用血。方法回顾性分析2013年10月~2017年2月上海交通大学医学院附属第九人民医院产科围生期输血的31例产妇的临床资料,分析输血成分使用情况。结果在31例输血孕产妇中,输注的血液成分主要为红细胞制品,其次为血浆及血小板。导致输血的产后出血病因主要为子宫收缩乏力。结论成分输血可有效地利用血液,改善凝血功能并止血,是孕产妇救治成功的关键措施;重视产前检查和规范诊治,掌握输血时机、合理用血,有助于降低输血率、减少输血量,降低孕产妇死亡率。Objective To guide timely and rational use of blood in clinic through the analysis of the application of the blood in the obstetric perinatal period. Methods The clinical data of 31 patients who delivered and received perinatal transfusion in Shanghai Ninth People＇s Hospital, Shanghai JiaoTong University School of Medicine from October 2013 to February 2017 was analyzed, and the utilization of blood components was retrospectively analyzed. Results The main infusion of blood components was red blood cell products, and the blood transfusion was mainly caused by uterine atony. Conclusion The blood component transfusion can contribute to effective utilization of the blood, improve the coagulation function and stop the bleeding, which is the key measure for maternal treatment. Besides, paying attention to prenatal examination and standardized diagnosis and treatment, and grasping the opportunity of blood transfusion and reasonable utilization of blood may contribute to cutting down the rate of blood transfusion, reducing the amount of blood transfusion, and reducing the maternal mortality.

关 键 词：围生期 成分输血 产后出血 

分 类 号：R457.1[医药卫生—治疗学]